Gonystylus keithii
Gonystylus keithii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Gonystylus keithii is a botanical species that has gained attention for its potential therapeutic properties in managing bone health. Researchers are specifically investigating the bioactive compounds found within the plant's leaf to address skeletal concerns. These studies focus on the plant's ability to mitigate the effects of bone resorption, a process that weakens the skeletal structure. Furthermore, its medicinal potential is being explored as a natural supplementary approach for individuals suffering from osteoporosis. Understanding the chemical makeup of its leaves may eventually offer new pathways for maintaining bone density and strength.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Thymelaeaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Gonystylus keithii is a notable plant species that is recognized by a diverse array of local names. Depending on the region, it is frequently referred to by the common names Bepisang or Letung. In other areas, the species may be known to locals as Malindah or Mangriau. Additionally, the name Saukau is also used to identify this particular plant within its natural habitat. These various nomenclature variations highlight the cultural and regional importance of the species across different landscapes.
Sources: Catalogue of Life (COL)
Taxonomy
Gonystylus keithii is a distinctive botanical specimen belonging to the vast kingdom Plantae. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the specific order Malvales, which helps define its evolutionary lineage. As a member of the genus Gonystylus, it displays unique characteristics shared by its close relatives. Finally, its biological identity is completed by its placement within the Thymelaeaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Thymelaeaceae |
| Genus | Gonystylus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Gonystylus keithii is a distinctive plant species primarily found within the tropical regions of Asia. Its natural distribution is concentrated throughout the Malesia botanical zone, highlighting its importance to the local ecosystem. A significant portion of its population resides within the lush rainforests of Borneo, where it thrives in specific environmental conditions. This geographic range underscores the unique biodiversity present across these Southeast Asian landscapes. Understanding its specific habitat is essential for the conservation efforts surrounding this valuable species.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Gonystylus keithii is a self-supporting plant that takes the form of a tree. It grows steadily in its natural habitat, eventually reaching a maximum height of 18 meters. This structural stability allows the species to thrive as a prominent component of its forest ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Gonystylus keithii contains gamma-pyrones that demonstrate significant potential in treating bone resorption. These specific compounds work by inhibiting the release of calcium induced by parathyroid hormone (PTH) from neonatal mouse calvaria. By effectively managing this calcium release, the plant offers a biological mechanism to address the underlying processes of bone loss. Consequently, these findings suggest that extracts from the plant could serve as the basis for treating osteoporosis. This makes the plant a promising source for developing new medicinal drugs aimed at bone health.
Preparations
Parts used
Gonystylus keithii serves as a vital source of bioactive compounds, specifically within its leaves. Researchers have successfully isolated several unique gamma-pyrones from these leafy portions of the plant. These identified compounds, including 9'-oxopodopyrone and 8-methyl-9'-oxopodopyrone, demonstrate a significant ability to inhibit calcium release. Specifically, they markedly suppress the release of calcium induced by parathyroid hormone in neonatal mouse calvaria. Such findings suggest that these plant derivatives could eventually serve as the foundation for developing new drugs to treat osteoporosis.